Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Richter's Transformation × selinexor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 38 Leukemia, Myeloid, Acute 21 Recurrence 19 Lymphoma, Large B-Cell, Diffuse 9 Sarcoma 7 Neoplasms, Plasma Cell 5 Glioblastoma 5 Neurofibrosarcoma 4 Neoplasms 4 Neoplasm Metastasis 4 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Colorectal Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Myelodysplastic Syndromes 3 Melanoma 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, B-Cell 3 Liposarcoma 3 Glioma 3 Endometrial Neoplasms 3 Carcinoma 3 Waldenstrom Macroglobulinemia 2 Thymoma 2 Sarcoma, Alveolar Soft Part 2 Rhabdoid Tumor 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Mantle-Cell 2 Leukemia, Myelomonocytic, Chronic 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02138786 2023-01-26

SIRRT

Karyopharm Therapeutics Inc

Phase 2 Terminated

27 enrolled 17 charts

Richter's Transformation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡